← Back to patent-cliff list
CAS 593-51-1
Methanamine hydrochlorideAminomethane hydrochloride
Codes: Lercanidipine Hydrochloride-048, (XIII)859946-1-a, Granisetron-013
Application context (from source-drug indications)
Essential hypertensionValsartan/Lercanidipine HydrochlorideHypertensionLercanidipine HydrochlorideBiliary tract cancerTasurgratinibBile duct cancerTasurgratinibSolid tumourTasurgratinibCholangiocarcinomaTasurgratinibBreast cancerTasurgratinibHepatic function declineTasurgratinibChemotherapy-induced nausea and vomitingGranisetronNauseaGranisetron呕吐Granisetron手术后恶心呕吐GranisetronPostoperative painGranisetronGastroparesisGranisetron
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Valsartan/Lercanidipine Hydrochloride | Tier C — Watch / trade | - |
| Lercanidipine Hydrochloride | Tier C — Watch / trade | - |
| Tasurgratinib | Tier C — Watch / trade | - |
| Granisetron | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-Phenylethan-1-one→Methanamine hydrochloride→3-(Methylamino)-1-phenylpropan-1-one→(+/-)-n-Methyl-3-hydroxy-3-phenylpropylamine→Benzene→N-(3,3-Diphenylpropyl)-N-methylamine hydrochloride
1-Phenylethan-1-one→Methanamine hydrochloride→3-(Methylamino)-1-phenylpropan-1-one→(+/-)-n-Methyl-3-hydroxy-3-phenylpropylamine→Benzene→N-(3,3-Diphenylpropyl)-N-methylamine hydrochloride
3,4-Dihydroxybenzaldehyde→1-Bromo-2-methoxyethane→3-Hydroxy-4-(2-methoxyethoxy)benzaldehyde→3-(Benzyloxy)-4-(2-methoxyethoxy)benzaldehyde→Nitrocarbol→2-(Benzyloxy)-1-(2-methoxyethoxy)-4-[(E)-2-nitroethenyl]benzene→6-(2-Methoxyethoxy)-1H-indol-5-ol→N-(4-Chloropyridin-2-yl)acetamide→2-Amino-4-chloropyridine→N-(4-[[6-(2-Methoxyethoxy)-1H-indol-5-yl]oxy]pyridin-2-yl)acetamide→4-[[6-(2-Methoxyethoxy)-1H-indol-5-yl]oxy]pyridin-2-amine→Phenyl methylcarbamate→Aminomethane hydrochloride→Carbonochloridic acid phenyl ester→1,4-Dioxane-2,5-diol→5-[(2-Aminopyridin-4-yl)oxy]-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide→4-[1-(tert-Butoxycarbonyl)piperidin-4-yl]benzoic acid→6-(2-Methoxyethoxy)-N-methyl-5-([2-[4-(piperidin-4-yl)benzamido]pyridin-4-yl]oxy)-1H-indole-1-carboxamide→2-Oxidanylethanal
2,3-Indolinedione→Iodomethane→1-Methyl-1H-indole-2,3-dione→3,3-Dimethoxy-1-methyl-1,3-dihydro-2H-indol-2-one→1-Methylindazole-3-carboxylic acid→1-Methyl-1H-indazole-3-carbonyl chloride→endo-9-Methyl-9-azabicyclo[3.3.1]nonan-3-amine→Glutaraldehyde→Methanamine hydrochloride→1,3-Acetonedicarboxylic acid→9-Methyl-9-azabicyclo[3.3.1]nonan-3-one→Hydroxylamine hydrochloride→N-Hydroxy-9-methyl-9-azabicyclo[3.3.1]nonan-3-imine→1-Methyl-2,3-dihydro-1H-indole
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.